Government News

- Read more about NPPA revised ceiling price of 24 formulations and retail price of 31 formulations
NPPA has revised ceiling price of 24 formulations and retail price of 31 formulations which includes from anticancer, antidiabetic, antiviral, antibacterial, antifungal etc portfolios.

[adsense:336x280:8701650588]
- Read more about New Indian FDI policy permits higher investment chances in Pharmaceuticals
Foreign Direct Investment (FDI) in Brownfield pharma sector has been permitted upto 74% under automatic route; and FDI beyond 74% and upto 100% is allowed under Government approval route.
- Read more about KCDA and Lupin penalised by CCI on anticompetitive conduct
The Competition Commission of India (Commission) has found the Karnataka Chemists and Druggist Association (KCDA) and Lupin Ltd. (Lupin) to be in contravention of the provisions of the Competition Act, 2002 (the Act). In a case filed by M/s Maruti & Co., it was brought to the notice of the Commission that KCDA restraints pharmaceutical companies from appointing new stockists in the State of Karnataka unless a No Objection Certificate (NOC) is obtained from it.
- Read more about Inclusion of coronary stent in NLEM is weakening the industry sentiment: FICCI
As the Indian medical device industry braces up for new opportunities, it remains tied up in the restrictive business environment. With the recent announcement on inclusion of coronary stent of all categories in National List of Essential Medicine the industry sentiment has further weakened.
India continues to win race in pharmaceuticals export over China as per government data. Pharmaceutical exports is leading China's export in important places like US, European Union (EU) and Africa. It is also noted that China's pharmaceutical export in EU & Africa is reducing gradually.

India’s pharmaceutical exports continued its lead over China in 2015. While India’s Pharma exports grew from USD 11.66 Billion to USD 12.54 Billion in 2015 recording a growth of 7.55%, China increased its exports of Pharma products from USD 6.59 Billion to USD 6.94 Billion showing a growth of 5.3% during the same period.

India moved ahead of China in all important markets such as US, European Union and Africa. India’s exports of Pharma products to US jumped from USD 3.84 Billion to USD 4.74 Billion, a growth of 23.4% as against China’s Pharma exports to US which moved from USD 1.16 Billion to USD 1.34 Billion in the same period showing a growth of 15%.

India maintained its lead with growth in EU and Africa recording exports of USD 1.5 Billion and USD 3.04 Billion respectively while China’s exports to EU & Africa showed a declining trend in both the markets.

<< Pharma News

Subscribe to PharmaTutor News Alerts by Email
30 June 2016

ICMR-CEEW launch the ‘solar for healthcare’ initiative

The Indian Council of Medical Research (ICMR) has signed an MoU with the Council on Energy, Environment and Water (CEEW), a policy research institution, to launch a new ‘Initiative on Solar for Healthcare’. The collaboration will focus on providing effective health care delivery at the last mile by reducing uncertainty in critical infrastructure, particularly electricity supply via cost effective solar-based solutions.
- Read more about Government withdrawn Drugs and Cosmetics Amendment Bill, 2013
The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, has decided to withdraw the Drugs and Cosmetics (Amendment) Bill, 2013, which had been introduced in the Rajya Sabha in 2013 by UPA government. The Bill had been examined by the Standing Committee of Parliament which had made a number of recommendations for changing the provisions of the Bill.
- Read more about Gelatin Capsules have technical advantage over HPMC Capsules: PHD Chamber to DCGI
The PHD Chamber of Commerce & Industry has made a representation to the Drug Controller General of India detailing the benefits of using Gelatine capsules over HPMC capsules in medicines.
- Read more about NPPA cut prices of 64 medicines
National Pharmaceuticals Pricing Authority (NPPA) has fixed prices of 64 important drug formulations and I.V. Fluids which are used for life threatening diseases or disorders like cancer, diabetes, cardio vascular diseases, pain killers, bacterial infections (antibiotics) etc.
- Read more about Soon, Animal Testing will be history in India
Government of India is considering to replace some animal tests with alternative methods in rabbits, guinea pigs or mice with respect to the approval of new drugs and therefore they are looking for replacements in Indian situation.

[adsense:336x280:8701650588]